Enliven Therapeutics, Inc. ($ELVN)
Filing Information
| Accession Number | 0001701247-26-000003 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 11, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
120,000
Total Value
$1,301,837.98
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF MEDICAL OFFICER | Common Stock | โ | Mar 9, 2026 | Exercise/Conversion | 29,871 | $2.48 | $74,080.08 | 54,871 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Mar 9, 2026 | Sale | 29,871 | $30.02 | $896,811.06 | 25,000 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Mar 10, 2026 | Exercise/Conversion | 10,129 | $2.48 | $25,119.92 | 35,129 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Mar 10, 2026 | Sale | 10,129 | $30.19 | $305,826.92 | 25,000 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Stock Option (right to buy) | Derivative | Mar 9, 2026 | Exercise/Conversion | 29,871 | $0.00 | $0.00 | 191,397 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Stock Option (right to buy) | Derivative | Mar 10, 2026 | Exercise/Conversion | 10,129 | $0.00 | $0.00 | 181,268 | Direct | โ | View Details |